Nemes Rush Group’s AstraZeneca AZN Stock Holding History

Nemes Rush Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.5K	Buy	+135	New	+$25.4K	﹤0.01%	458
2026 Q1	–	Sell	-135	Closed	-$24.8K	–	951
2025 Q4	$24.8K	Buy	135 +83	+160%	+$14.6K	﹤0.01%	435
2025 Q3	$7.87K	Sell	52 -26	-33%	-$3.94K	﹤0.01%	509
2025 Q2	$10.9K	Buy	78 +27	+53%	+$3.78K	﹤0.01%	464
2025 Q1	$7.5K	Sell	51 -15	-23%	-$2.17K	﹤0.01%	498
2024 Q4	$8.62K	Buy	66 +16	+32%	+$2.24K	﹤0.01%	486
2024 Q3	$6.78K	Hold	50	–	–	﹤0.01%	437
2024 Q2	$7.8K	Sell	50 -230	-82%	-$34.6K	﹤0.01%	429
2024 Q1	$37.9K	Sell	280 -1	-0.4%	-$132	0.01%	315
2023 Q4	$37.8K	Buy	281 +67	+31%	+$8.71K	0.01%	295
2023 Q3	$29K	Buy	214 +169	+376%	+$23.1K	0.01%	303
2023 Q2	$6.44K	Buy	+45	New	+$6.62K	﹤0.01%	467

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nemes Rush Group's AZN Position: Q2 2026 in Review

Nemes Rush Group opened a new position in AstraZeneca (AZN) in Q2 2026: 135 shares worth $25.5K. The stake represents ﹤0.01% of the portfolio and ranks #458 among its holdings. This is a return to the name: Nemes Rush Group previously reported a position in AZN as recently as Q4 2025.

Nemes Rush Group first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. The position peaked at $37.9K in Q1 2024. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Nemes Rush Group held 135 shares of AstraZeneca worth $25.5K as of Q2 2026.
AstraZeneca was a new Nemes Rush Group position in Q2 2026.
AstraZeneca made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #458 holding.
Nemes Rush Group first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
Nemes Rush Group's AstraZeneca position peaked at $37.9K in Q1 2024.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.